PAVmed (PAVM) Other Non Operating Income (2017 - 2025)
PAVmed's (PAVM) quarterly Other Non Operating Income came in at -$116000.0 in Q4 2025, up 92.4% year-on-year from -$60291.6 in Q4 2024, and down 200.0% quarter-over-quarter from $116000.0 in Q3 2025.
PAVmed (PAVM) Other Non Operating Income (2017 - 2025) Analysis & Trends
PAVmed's Other Non Operating Income history runs 9 years deep, the most recent figure standing at -$116000.0 for Q4 2025.
- On a quarterly basis, Other Non Operating Income rose 92.4% year-over-year to -$116000.0 in Q4 2025; TTM through Dec 2025 was -$58000.0, a 98.3% increase from a year earlier, with the FY2025 full-year figure at -$58000.0, up 97.71% from the prior year.
- Other Non Operating Income retreated to -$116000.0 in Q4 2025 per PAVM's latest filing, from $116000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $72.3 million in Q3 2024 and bottomed at -$5.6 million in Q2 2022.
- The 5-year median for Other Non Operating Income is -$525000.0 (2023), against an average of $2.7 million.
- Across the five-year window, Other Non Operating Income sank 26350.0% in 2023 and soared 115.72% in 2025, its largest moves.
- Year by year, Other Non Operating Income stood at -$2.0 million in 2021, then surged by 101.46% to $29000.0 in 2022, then sank by 2686.21% to -$750000.0 in 2023, then sank by 103.47% to -$1.5 million in 2024, then jumped by 92.4% to -$116000.0 in 2025.
- Per Business Quant, the three latest PAVM Other Non Operating Income figures stand at -$116000.0 (Q4 2025), $116000.0 (Q3 2025), and -$116000.0 (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | PAVmed | 9.85 Mn | -3.35 Mn | -4,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -116,000.00 |
| Sep 30, 2025 | 116,000.00 |
| Jun 30, 2025 | -116,000.00 |
| Mar 31, 2025 | 58,000.00 |
| Dec 31, 2024 | -1.53 Mn |
| Sep 10, 2024 | 72.29 Mn |
| Jun 30, 2024 | -763,000.00 |
| Mar 31, 2024 | -369,000.00 |
| Dec 31, 2023 | -750,000.00 |
| Sep 30, 2023 | -1.76 Mn |
| Jun 30, 2023 | -743,000.00 |
| Mar 31, 2023 | -525,000.00 |
| Dec 31, 2022 | 29,000.00 |
| Sep 30, 2022 | -5.12 Mn |
| Jun 30, 2022 | -5.62 Mn |
| Mar 31, 2022 | 2,000.00 |
| Dec 31, 2021 | -1.98 Mn |
| Jun 30, 2021 | 300,000.00 |
| Mar 31, 2021 | -2.03 Mn |
| Dec 31, 2020 | -1.70 Mn |